Commentary on Perrone et al.: 'Vitamin C: Not for breakfast anymore... if you have myeloma'

Leukemia

Volumn 23, Issue 11, 2009, Pages 1939-1940

  Harvey, R D ^a   Nettles, J ^a   Wang, B ^b   Sun, S Y ^a   Lonial, S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BORTEZOMIB; MELPHALAN;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; DRUG EFFICACY; DRUG POTENTIATION; DRUG STRUCTURE; DRUG TARGETING; HUMAN; MYELOMA; NOTE; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ASCORBIC ACID; BORONIC ACIDS; DRUG INTERACTIONS; HUMANS; MULTIPLE MYELOMA; PYRAZINES;

EID: 70450189443     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.128     Document Type: Note

References (10)

1. Perrone G, Hideshima T, Ikeda H, Okawa Y, Calabrese E, Gorgun G et al Ascorbic acid inhibits antitumor activity of bortezomib in vivo. Leukemia 2009; 23: 1679-1686.
2. Zou W, Yue P, Lin N, He M, Zhou Z, Lonial S et al. Vitamin C inactivates the proteasome inhibitor PS-341 in human cancer cells. Clin Cancer Res 2006; 12: 273-280.
3. Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG et al Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009; 113 5927-5937.
4. Nettles JH, Jenkins JL, Bender A, Deng Z, Davies JW, Glick M. Bridging chemical and biological space: 'target fishing' using 2D and 3D molecular descriptors. J Med Chem 2006; 49: 6802-6810.
5. Scheiber J, Chen B, Milik M, Sukuru SC, Bender A, Mikhailov D et al Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis. J Chem Inf Model 2009; 49: 308-317.
6. Scheiber J, Jenkins JL, Sukuru SC, Bender A, Mikhailov D, Milik M et al. Mapping adverse drug reactions in chemical space. J Med Chem 2009; 52: 3103-3107.
7. Durken M, Herrnring C, Finckh B, Nagel S, Nielsen P, Fischer R et al Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation. Free Radic Biol Med 2000; 28: 887-894.
8. Berenson JR, Yellin O, Woytowitz D, Flam MS, Cartmell A, Patel R et al. Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: An effective and well-tolerated frontline regimen. Eur J Haematol 2009; 82: 433-439.
9. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000; 18: 2505-2514.
10. Springsteen G, Wang B. A detailed examination of boronic aciddiol complexation. Tetrahedron 2002; 58: 5291-5300.